YC
RMD icon

Yarbrough Capital’s ResMed RMD Stock Holding History

Yarbrough Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,252
Closed -$783K – 133
2025
Q4 		$783K Hold
3,252
– – 0.02% 96
2025
Q3 		$890K Hold
3,252
– – 0.03% 93
2025
Q2 		$839K Buy
3,252
+1,381
+74% +$329K 0.03% 102
2025
Q1 		$419K Hold
1,871
– – 0.02% 145
2024
Q4 		$428K Hold
1,871
– – 0.02% 136
2024
Q3 		$457K Buy
+1,871
New +$418K 0.02% 140

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Yarbrough Capital's RMD Position: Q1 2026 in Review

Yarbrough Capital sold out of ResMed (RMD) in Q1 2026, closing a stake of 3,252 shares — an estimated $783K sold.

Yarbrough Capital first reported a position in RMD in Q3 2024 and held it in 6 quarters. The position peaked at $890K in Q3 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Yarbrough Capital reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Yarbrough Capital sold 3,252 ResMed shares in Q1 2026, an estimated $783K.
  • Yarbrough Capital first reported a position in ResMed in Q3 2024 and held it in 6 quarters.
  • Yarbrough Capital's ResMed position peaked at $890K in Q3 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Yarbrough Capital's 13F filing for Q1 2026, filed 14 Apr 2026.